ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison.
Cardiovascular Clinic Institute, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.
Salvatore
S
Brugaletta
Deutsches Zentrum für Herz und Kreislauf Forschung, Standort Rhein-Main, Mainz, Germany.
Tommaso
T
Gori
Cardiac Department, National University Heart Centre Singapore, National University Health System, Singapore.
Adrian F
AF
Low
Cardiocenter, Third Faculty of Medicine, Charles University in Prague, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
Petr
P
Tousek
Cardiology Department, Interventional Cardiology Unit, Virgen de la Arrixaca Hospital, Murcia, Spain.
Eduardo
E
Pinar
Institute of Cardiology, Hospital of Bellvitge, Barcelona, Spain.
Josep
J
Gomez-Lara
Cardiovascular Clinic Institute, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.
Luis
L
Ortega-Paz
Deutsches Zentrum für Herz und Kreislauf Forschung, Standort Rhein-Main, Mainz, Germany.
Eberhard
E
Schulz
Cardiac Department, National University Heart Centre Singapore, National University Health System, Singapore.
Mark Y
MY
Chan
Cardiocenter, Third Faculty of Medicine, Charles University in Prague, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
Viktor
V
Kocka
Cardiology Department, Interventional Cardiology Unit, Virgen de la Arrixaca Hospital, Murcia, Spain.
Jose
J
Hurtado
Institute of Cardiology, Hospital of Bellvitge, Barcelona, Spain.
Joan Antoni
JA
Gomez-Hospital
Cardiovascular Clinic Institute, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.
Giuseppe
G
Giacchi
Deutsches Zentrum für Herz und Kreislauf Forschung, Standort Rhein-Main, Mainz, Germany.
Thomas
T
Münzel
Cardiac Department, National University Heart Centre Singapore, National University Health System, Singapore.
Chi-Hang
CH
Lee
Institute of Cardiology, Hospital of Bellvitge, Barcelona, Spain.
Angel
A
Cequier
Cardiology Department, Interventional Cardiology Unit, Virgen de la Arrixaca Hospital, Murcia, Spain.
Mariano
M
Valdés
Cardiocenter, Third Faculty of Medicine, Charles University in Prague, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
Petr
P
Widimsky
Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.
Patrick W
PW
Serruys
Cardiovascular Clinic Institute, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.
Manel
M
Sabaté
D020341:Absorbable Implants; D054855:Drug-Eluting Stents; D000068338:Everolimus / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D057216:Propensity Score; D019919:Prosthesis Implantation / Q000295:instrumentation*; D000072657:ST Elevation Myocardial Infarction / Q000628:therapy*; D016019:Survival Analysis; D054457:Tissue Scaffolds; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D000068338:Everolimus
BVS; Everolimus-eluting stent; STEMI